Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?

Key Takeaways ISRG's Ion platform recorded significant growth in the third quarter with 52% procedure growth.Study data demonstrated 84.6% diagnostic yield for ISRG's Ion compared to conventional bronchoscopy.Adoption of ISRG's Ion platform boosted lung cancer detection, implying higher procedure growth potential.Intuitive Surgical’s (ISRG) third-quarter performance highlights a pivotal shift in its platform mix, with robotic bronchoscopy, formerly a peripheral initiative, rapidly emerging as a core growth ...